← Back to Search

Carotenoid Supplement

Carotenoid Supplements for Children's Cognitive Function and Achievement

N/A
Recruiting
Led By Naiman Khan, PhD
Research Sponsored by University of Illinois at Urbana-Champaign
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
8-10 years of age
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months (baseline vs follow-up)
Awards & highlights

Study Summary

This trial will test if taking a carotenoid supplement can improve cognitive function and achievement in schoolchildren.

Who is the study for?
This trial is for children aged 8-10 with normal or corrected vision and no recent lutein supplementation. They must not have a learning disability, be in early puberty (Tanner scale ≤2), and have both child assent and parent/guardian consent.Check my eligibility
What is being tested?
The study tests if taking carotenoid supplements can improve cognitive function and academic achievement in children over a school year, compared to a waitlist group receiving a placebo.See study design
What are the potential side effects?
The information provided does not specify side effects; however, as with any supplement, there may be potential risks which will be monitored throughout the trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 8 and 10 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months (baseline vs follow-up)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months (baseline vs follow-up) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Attentional Accuracy
Attentional Reaction Time
Composite Academic Achievement
+1 more
Secondary outcome measures
Attentional Processing Speed
Attentional Resource Allocation
Macular Pigment Optical Density
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active SupplementExperimental Treatment1 Intervention
The active supplementation group participants will be asked to consume a daily carotenoid supplement for 9 months.
Group II: Placebo ControlPlacebo Group1 Intervention
The placebo control group participants will be asked to consume a placebo supplement for 9 months.

Find a Location

Who is running the clinical trial?

University of Illinois at Urbana-ChampaignLead Sponsor
188 Previous Clinical Trials
37,047 Total Patients Enrolled
Northeastern UniversityOTHER
88 Previous Clinical Trials
61,022 Total Patients Enrolled
University of GeorgiaOTHER
100 Previous Clinical Trials
34,370 Total Patients Enrolled

Media Library

Active supplement (Carotenoid Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05177679 — N/A
Cognitive Impairment Research Study Groups: Placebo Control, Active Supplement
Cognitive Impairment Clinical Trial 2023: Active supplement Highlights & Side Effects. Trial Name: NCT05177679 — N/A
Active supplement (Carotenoid Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05177679 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the key goals of this clinical research project?

"The purpose of this 9-month trial is to analyse Composite Academic Achievement. Secondary outcomes will be measured on the KTEA III Reading subtest (standard scores between 40 and 160, where higher equals better performance) and Reading Fluency subtests (also standard scores between 40 and 160). Finally, Macular Pigment Optical Density changes are being observed using a macular densitometer."

Answered by AI

What is the capacity of the current clinical trial?

"Affirmative. Information on clinicaltrials.gov confirms that, first posted on June 1st 2022, this research endeavour is actively recruiting patients for participation. 288 individuals need to be recruited from a single medical centre."

Answered by AI

Does this research opportunity permit me to join its cohort?

"To fulfill the admissions criteria, applicants must be between 8 and 10 years of age and have attained a certain level of accomplishment. This clinical trial is currently recruiting 288 participants in total."

Answered by AI

Is recruitment open for this trial?

"According to records stored on clinicaltrials.gov, recruitment for this medical trial is ongoing since its launch in June 1st 2022 and last update 16th May 2022."

Answered by AI

Are persons aged 85 or younger qualified for participation in this test?

"To be considered for this medical trial, applicants must fall between the age of 8 and 10 years old. Additionally, there are at least 8 trials designed specifically to enroll minors while 36 clinical studies seek participants over 65 years in age."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Enhancing Children's Cognitive Function and Achievement Through Carotenoid Consumption
2022. "Enhancing Children's Cognitive Function and Achievement Through Carotenoid Consumption". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05177679.
~107 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top